CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Clyburn Frank EVP & Pres ? Human Health | Option exercise · Stock Option (Right to Buy) | −19,847 | 19,848 | ||
| 2021-10-30 | Clyburn Frank EVP & Pres ? Human Health | Option exercise | +2,358 | $88.05 | $208K | 98,257.09 |
| 2021-10-30 | Clyburn Frank EVP & Pres ? Human Health | Shares withheld for taxes | −1,162 | $88.05 | $102K | 97,095.09 |
| 2021-10-30 | Clyburn Frank EVP & Pres ? Human Health | Option exercise · Restricted Stock Unit | −2,358 | 0 | ||
| 2021-10-30 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise | +4,715 | $88.05 | $415K | 27,896.15 |
| 2021-10-30 | MIZELL STEVEN EVP, Chief HR Officer | Shares withheld for taxes | −2,323 | $88.05 | $205K | 25,573.15 |
| 2021-10-30 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise · Restricted Stock Unit | −4,715 | 0 | ||
| 2021-10-29 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise | +24,619 | 117,764.36 | ||
| 2021-10-29 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −24,619 | $87.32 | $2.1M | 93,145.36 |
| 2021-10-29 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise · Stock Option (Right to Buy) | −24,619 | 15,213 | ||
| 2021-10-29 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +73,026 | 189,955.96 | ||
| 2021-10-29 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +62,379 | 252,334.96 | ||
| 2021-10-29 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Sale | −135,405 | $87.56 | $11.9M | 116,929.96 |
| 2021-10-29 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −73,026 | 0 | ||
| 2021-10-29 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −62,379 | 0 | ||
| 2021-09-30 | WENDELL PETER C Director | Grant or award · Phantom Stock | +399.41 | $75.11 | $30K | 108,899.78 |
| 2021-09-30 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +116.5 | $75.11 | $9K | 79,121.69 |
| 2021-09-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +216.35 | $75.11 | $16K | 6,840.42 |
| 2021-05-04 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Restricted Stock Unit | +26,319 | 26,319 | ||
| 2021-05-04 | Clyburn Frank EVP & Pres ? Human Health | Grant or award · Restricted Stock Unit | +39,479 | 39,479 |
Page 41 of 42 · 823 trades